Status:
COMPLETED
Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
The erector spinae plane block (ESPB) is gaining popularity as a regional anesthetic technique for major breast cancer surgery. Although there is controversy about its mechanism of action, emerging ev...
Detailed Description
Major Breast Cancer Surgery (BCS), including mastectomy or modified radical mastectomy (MRM), is a globally prevalent procedure. Unfortunately, it is associated not only with significant acute postope...
Eligibility Criteria
Inclusion
- ASA I-III patients
- 18 to 75 years of age
- Patients scheduled for primary breast cancer surgery-mastectomy, modified radical mastectomy and breast conservation surgery with sentinel lymph node biopsy +/- axillary dissection will be included in this study.
Exclusion
- Patient refusal,
- Local skin site infection,
- Coagulopathy,
- History of allergy to local anaesthetics, and
- Patients with hepatic, renal and cardiac dysfunction
Key Trial Info
Start Date :
October 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06490718
Start Date
October 25 2024
End Date
July 20 2025
Last Update
September 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital
Guangzhou, Guangdong, China
2
North District Hospital
Sheung Shui, Hong Kong, 999077